We're Hopeful That Stoke Therapeutics (NASDAQ:STOK) Will Use Its Cash Wisely
Skorpios Trust Sells $27.2 Million of Stoke Therapeutics Stock
Express News | Skorpios Trust Reports 16.9% Stake in Stoke Therapeutics as of Sept 19 Vs 23.4% as of April 17- SEC Filing
Form 144 | Stoke Therapeutics(STOK.US) Insider Proposes to Sell 29.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 19, $Stoke Therapeutics(STOK.US)$ Insider Blue Horizon E LTD intends to sell 1.94 million shares of its common stock on Sep 19, with a total market value of approximately $
TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy Rating
TD Cowen analyst Yaron Werber maintains $Stoke Therapeutics(STOK.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 60.9% and a total average return of 16.1% over
Stoke Therapeutics (STOK) Gets a Buy From TD Cowen